Clinical trial
Repetitive Transcranial Magnetic Stimulation for Suicidality in Opioid Use Disorders
NCT04785456 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repetitive Transcranial Magnetic Stimulation for Suicidality in Opioid Use Disorders
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2022
- Completion date
- March 1, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depressive disorder, opioid-use disorder